Skip to main content
Top
Published in: Rheumatology International 1/2011

01-01-2011 | Original Article

Serum melatonin levels in ankylosing spondilitis: correlation with disease activity

Authors: Kazim Senel, Tuba Baykal, Meltem Alkan Melikoglu, Akin Erdal, Saliha Karatay, Akar Karakoc, Mahir Ugur

Published in: Rheumatology International | Issue 1/2011

Login to get access

Abstract

This study was carried out to determine the serum levels of melatonin (MLT) in patients with ankylosing spondilitis (AS) and to evaluate its correlation with disease activity. We assessed clinical characteristics and labaratory parameters. Serum samples from 36 patients (25 males, 11 females) with active AS and 25 healthy subjects (18 males, 7 females) were collected. MLT levels were measured by enzyme-linked immunosorbent assay, and disease activity of AS was assessed according to the Bath AS disease activity index (BASDAI), the erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP). Then, the results were compared with those from 25 healty controls. The serum levels of MLT were significantly increased in AS patients as compared to healthy controls (p < 0.05). MLT levels were correlated with BASDAI (r = 0.871, p < 0.001) and CRP levels (r = 0.691, p < 0.001), but not with ESR, in patients with AS. Our results suggest a possible role for this immunoregulatory hormone in the disease activity in AS patients.
Literature
1.
go back to reference Maksymowych WP (2003) Spondyloartropathies: etiology and pathogenesis of ankylosing spondylitis. In: Hochberg M, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH (eds) Rheumatology, 3rd edn. Elsevier, Philadelphia, pp 1183–1192 Maksymowych WP (2003) Spondyloartropathies: etiology and pathogenesis of ankylosing spondylitis. In: Hochberg M, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH (eds) Rheumatology, 3rd edn. Elsevier, Philadelphia, pp 1183–1192
2.
go back to reference Reiter RJ, Melchiorri D, Seweryrek E, Poeggeler B, Barlow-Walden L, Chuang J et al (1995) A review of the evidence supporting melatonin’s role as an antioxidant. J Pineal Res 18:1–11CrossRefPubMed Reiter RJ, Melchiorri D, Seweryrek E, Poeggeler B, Barlow-Walden L, Chuang J et al (1995) A review of the evidence supporting melatonin’s role as an antioxidant. J Pineal Res 18:1–11CrossRefPubMed
3.
go back to reference Reiter RJ, Calvo JR, Karbownik M, Qi WB, Tan DX (2000) Melatonin and its relation to the immune system and inflammation. Ann N Y Acad Sci 917:376–386CrossRefPubMed Reiter RJ, Calvo JR, Karbownik M, Qi WB, Tan DX (2000) Melatonin and its relation to the immune system and inflammation. Ann N Y Acad Sci 917:376–386CrossRefPubMed
4.
5.
go back to reference Pandi-Perumal SR, Srinivasan V, Maestroni GJM, Cardinali DP, Poegaler B, Hardeland R (2006) Melatonin. Nature ‘s most versatile biological singnal? FEBS J 273:2813–2838CrossRefPubMed Pandi-Perumal SR, Srinivasan V, Maestroni GJM, Cardinali DP, Poegaler B, Hardeland R (2006) Melatonin. Nature ‘s most versatile biological singnal? FEBS J 273:2813–2838CrossRefPubMed
6.
7.
go back to reference Altun A, Ugur-Altun B (2007) Melatonin.Therapeutic and clinical utilization. Int J Clin Pract 61:835–845CrossRefPubMed Altun A, Ugur-Altun B (2007) Melatonin.Therapeutic and clinical utilization. Int J Clin Pract 61:835–845CrossRefPubMed
8.
go back to reference Szczepanik M (2007) Melatonin and its influence on immune system. J Physiol Pharmacol 58(Suppl 6):115–124PubMed Szczepanik M (2007) Melatonin and its influence on immune system. J Physiol Pharmacol 58(Suppl 6):115–124PubMed
9.
go back to reference Forrest CM, Mackay GM, Stoy N, Stone TW, Darlington LG (2007) Inflammatory status and kynurenine metabolism in rheumatoid arthritis treated with melatonin. Br J Clin Pharmacol 64:517–526CrossRefPubMed Forrest CM, Mackay GM, Stoy N, Stone TW, Darlington LG (2007) Inflammatory status and kynurenine metabolism in rheumatoid arthritis treated with melatonin. Br J Clin Pharmacol 64:517–526CrossRefPubMed
10.
go back to reference Cutolo M, Otsa K, Aakr O, Sulli A (2005) Nocturnal hormones and clinical rhythms in rheumatoid arthritis. Ann N Y Acad Sci 1051:372–381CrossRefPubMed Cutolo M, Otsa K, Aakr O, Sulli A (2005) Nocturnal hormones and clinical rhythms in rheumatoid arthritis. Ann N Y Acad Sci 1051:372–381CrossRefPubMed
11.
go back to reference Cutolo M, Maestroni GJ, Otsa K, Aakre O, Villaggio B, Capellino S et al (2005) Cirdacidian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: a north and south Europe comparison. Ann Rheum Dis 64:212–216CrossRefPubMed Cutolo M, Maestroni GJ, Otsa K, Aakre O, Villaggio B, Capellino S et al (2005) Cirdacidian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: a north and south Europe comparison. Ann Rheum Dis 64:212–216CrossRefPubMed
12.
go back to reference West SK, Oosthuizen JM (1992) Melatonin Levels are decreased in rheumatoid arthritis. J Basic Clin Physiol Pharmacol 3:33–40PubMed West SK, Oosthuizen JM (1992) Melatonin Levels are decreased in rheumatoid arthritis. J Basic Clin Physiol Pharmacol 3:33–40PubMed
13.
go back to reference Reiter RJ, Tan DX, Manchester CC, Pilar Terron M, Flores LJ, Koppisepi S (2007) Medical implications of melatonin: receptor-mediated and receptor-independent actions. Adv Med Sci 52:11–28PubMed Reiter RJ, Tan DX, Manchester CC, Pilar Terron M, Flores LJ, Koppisepi S (2007) Medical implications of melatonin: receptor-mediated and receptor-independent actions. Adv Med Sci 52:11–28PubMed
14.
go back to reference Cutolo M, Seriolo B, Craviotta C, Pizzorni C, Sulli A (2003) Circadian rhytms in RA. Ann Rheum Dis 62:593–596CrossRefPubMed Cutolo M, Seriolo B, Craviotta C, Pizzorni C, Sulli A (2003) Circadian rhytms in RA. Ann Rheum Dis 62:593–596CrossRefPubMed
15.
go back to reference Cutolo M, Villaggio B, Otsa K, Aakre O, Sulli A, Seriolo B (2005) Altered circadian rhythms in rheumatoid arthritis patients play a role in the disease symptoms. Autoimmun Rev 4:497–502CrossRefPubMed Cutolo M, Villaggio B, Otsa K, Aakre O, Sulli A, Seriolo B (2005) Altered circadian rhythms in rheumatoid arthritis patients play a role in the disease symptoms. Autoimmun Rev 4:497–502CrossRefPubMed
16.
go back to reference Cutolo M, Maestroni GJM (2005) The melatonin–cytokine connection in rheumatoid arthritis. Ann Rheum Dis 64:1109–1111CrossRefPubMed Cutolo M, Maestroni GJM (2005) The melatonin–cytokine connection in rheumatoid arthritis. Ann Rheum Dis 64:1109–1111CrossRefPubMed
17.
go back to reference Maestroni GJ, Cardinali DP, Esquifino AI, Pandi-Perumal SR (2005) Does melatonin play a disease-promoting role in rheumatoid arthritis? J Neuroimmunol 158:106–111CrossRefPubMed Maestroni GJ, Cardinali DP, Esquifino AI, Pandi-Perumal SR (2005) Does melatonin play a disease-promoting role in rheumatoid arthritis? J Neuroimmunol 158:106–111CrossRefPubMed
18.
go back to reference Sulli A, Maestroni GJ, Villaggio B, Hertens E, Craviotto C, Pizzorni C et al (2002) Melatonin serum levels in rheumatoid arthritis. Ann N Y Acad Sci 966:276–278CrossRefPubMed Sulli A, Maestroni GJ, Villaggio B, Hertens E, Craviotto C, Pizzorni C et al (2002) Melatonin serum levels in rheumatoid arthritis. Ann N Y Acad Sci 966:276–278CrossRefPubMed
19.
go back to reference Maestroni GJ, Sulli A, Pizzorni C, Villaggio B, Cutolo M (2002) Melatonin in rheumatoid arthritis: synovial macrophages show melatonin receptors. Ann N Y Acad Sci 966:271–275CrossRefPubMed Maestroni GJ, Sulli A, Pizzorni C, Villaggio B, Cutolo M (2002) Melatonin in rheumatoid arthritis: synovial macrophages show melatonin receptors. Ann N Y Acad Sci 966:271–275CrossRefPubMed
20.
go back to reference Wollmann HA, Pleyer U, Friedel S (1994) Neuro endocrine alterations in uveits patients. Graefes Arch Clin Exp Ophthalmol 232:297–301CrossRefPubMed Wollmann HA, Pleyer U, Friedel S (1994) Neuro endocrine alterations in uveits patients. Graefes Arch Clin Exp Ophthalmol 232:297–301CrossRefPubMed
21.
go back to reference Ha E, Choe BK, Jung KH, Yoon SH, Park HJ, Park HK (2005) Positive relationship between melatonin receptor type 1 B polymorphism and rheumatoid factor in rheumatoid arthritis patients in the Korean population. J Pineal Res 39:201–205CrossRefPubMed Ha E, Choe BK, Jung KH, Yoon SH, Park HJ, Park HK (2005) Positive relationship between melatonin receptor type 1 B polymorphism and rheumatoid factor in rheumatoid arthritis patients in the Korean population. J Pineal Res 39:201–205CrossRefPubMed
Metadata
Title
Serum melatonin levels in ankylosing spondilitis: correlation with disease activity
Authors
Kazim Senel
Tuba Baykal
Meltem Alkan Melikoglu
Akin Erdal
Saliha Karatay
Akar Karakoc
Mahir Ugur
Publication date
01-01-2011
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 1/2011
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-1223-x

Other articles of this Issue 1/2011

Rheumatology International 1/2011 Go to the issue